Generate Biomedicines, Inc. logo

Generate Biomedicines, Inc. (GENB)

Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
15. 79
+0.52
+3.4054%
$
2.61B Market Cap
- P/E Ratio
- Div Yield
1.04M Volume
- Eps
$ 15.27
Previous Close
Add Transaction
Day Range
14.93 15.99
Year Range
11 22.67
Want to track GENB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Generate Biomedicines, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
John H. Burbank III
John H. Burbank III Passport Capital LLC
1.42M $17.8M $22.27M $4.47M 25.12%
NM
Nir Messafi Deep Track Capita LLP
1.33M $22.55M $20.86M -$1.69M -7.51%
Joseph Castro
Joseph Castro Nuveen LLC
44,470 $750,209 $654,598.4 -$95,610.6 -12.74%
MPM
Mark P. Mennitt CenterBook Partners LP
131,560 $1.64M $1.94M $292,063.2 17.76%
Taro Kuriyama
Taro Kuriyama Axq Capita LLP
12,946 $218,399 $181,244 -$37,155 -17.01%
KJ
Ken Joseph Braidwel LLP
3.28M $41.05M $51.36M $10.31M 25.12%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
1 $17 $14 -$3 -17.65%
Kevin Bresler
Kevin Bresler TD Waterhouse Canada Inc.
573 $9,460 $8,022 -$1,438 -15.2%
Raymond Debbane
Raymond Debbane Siren, L.L.C.
736,104 $9.2M $11.11M $1.91M 20.72%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
7,200 $121,464 $100,800 -$20,664 -17.01%
SCL
Stance Capital LLC Stance Capital LLC
1,384 $23,348 $21,645.76 -$1,702.24 -7.29%